Ryman Healthcare Ltd
XBER:RH7

Watchlist Manager
Ryman Healthcare Ltd Logo
Ryman Healthcare Ltd
XBER:RH7
Watchlist
Price: 1.441 EUR Market Closed
Market Cap: €720.5m

Wall St Price Targets

RH7 Price Targets Summary
Ryman Healthcare Ltd

Wall Street analysts forecast RH7 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RH7 is 1.965 EUR with a low forecast of 1.71 EUR and a high forecast of 2.454 EUR.

Lowest Forecast
Price Target
1.71 EUR
19% Upside
Average Forecast
Price Target
1.965 EUR
36% Upside
Highest Forecast
Price Target
2.454 EUR
70% Upside
Ryman Healthcare Ltd Competitors:
Price Targets
NTHI
NeOnc Technologies Holdings Inc
181% Upside
FILA
FILA Fabbrica Italiana Lapis ed Affini SpA
50% Upside

Revenue
Forecast

13% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss
13% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 9%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-79%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-79%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RH7's stock price target?
Price Target
1.965 EUR

According to Wall Street analysts, the average 1-year price target for RH7 is 1.965 EUR with a low forecast of 1.71 EUR and a high forecast of 2.454 EUR.

What is the Revenue forecast for Ryman Healthcare Ltd?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 9%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett